"Before the pandemic, under the Ryan Haight Online Pharmacy Consumer Protection Act (2008), providers were generally required to perform an in-person medical evaluation before prescribing controlled substances via telemedicine. But in March 2020, during the public health emergency, the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) invoked an exception under the Act to allow prescribing of controlled medications via telemedicine without the prior in-person visit."
"We have been told that the involved agencies continue to work toward a new regulatory framework (proposed "special registration" pathways) that would establish telehealth as a long-term viable care option. As of this week, according to McDermott, Will, and Schulte, "A new rule posted on the Office of Management and Budget registry suggests that the US Drug Enforcement Administration is planning an additional extension of COVID-19-era flexibilities for telemedicine prescribing of controlled substances beyond the current expiration date of December 31, 2025.""
Providers face uncertainty about whether temporary telehealth prescribing flexibilities will expire on December 31, 2025. Before COVID-19, the Ryan Haight Online Pharmacy Consumer Protection Act required an in-person medical evaluation before prescribing controlled substances via telemedicine. In March 2020, during the public health emergency, the DEA and HHS invoked an exception to allow prescribing of controlled medications via telemedicine without a prior in-person visit. A third temporary extension is currently in effect and agencies are reportedly working on proposed 'special registration' pathways to create a permanent regulatory framework. The possibility of further extension has prompted calls to reframe telehealth and establish standards equal to in-person care.
Read at Psychology Today
Unable to calculate read time
Collection
[
|
...
]